The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

PULMONARY HYPERTENSION DIAGNOSIS AND FOLLOW-UP

Pulmonary hypertension diagnosis and follow-up — classification and management of elevated pulmonary artery pressure.

Process in which elevated pressure in the pulmonary arteries is diagnosed by echocardiography and right heart catheterization, and a group-based treatment plan is established.

Indication

  • Unexplained progressive shortness of breath and reduced exercise capacity
  • Syncope, chest pain, and palpitation complaints
  • Evaluation in known heart failure or congenital heart disease
  • Suspicion in the setting of chronic lung disease (COPD, pulmonary fibrosis)
  • Suspected chronic thromboembolic pulmonary hypertension (CTEPH) after a previous pulmonary embolism
  • Follow-up of connective tissue diseases (scleroderma, lupus)
  • Family history of pulmonary arterial hypertension (PAH)

Preparation

  • Current medication list and previous illnesses are reviewed
  • Fasting for 6 hours before right heart catheterization
  • Coagulation tests and renal function are checked
  • Use of blood-thinning medications is regulated with physician approval
  • Comfortable clothing and a companion are recommended on the day of the procedure

How it's performed

  1. Detailed cardiopulmonary examination and ECG
  2. Echocardiography (ECHO) for estimation of systolic pulmonary artery pressure
  3. Pulmonary function tests and 6-minute walk test
  4. Thoracic CT, V/Q scan (for CTEPH differential diagnosis)
  5. Right heart catheterization for definitive pressure measurement
  6. Classification: PAH (Group 1, including primary/idiopathic), left heart disease (Group 2), lung disease (Group 3), CTEPH (Group 4), multifactorial (Group 5)

Post-procedure

  • Group-specific treatment: in PAH, endothelin receptor antagonists, PDE5 inhibitors, prostacyclin analogues
  • In Group 2-3, treatment of the underlying disease takes priority
  • Evaluation for pulmonary endarterectomy or balloon pulmonary angioplasty in CTEPH
  • ECHO, 6-minute walk test, and BNP/NT-proBNP follow-up every 3-6 months
  • Exercise prescription and vaccination (influenza, pneumococcus) recommendation

Risks

  • Rare bleeding, arrhythmia, or vascular damage during right heart catheterization
  • Side effects related to PAH medications (headache, hypotension, elevated liver enzymes)
  • Development of right heart failure in untreated cases
  • Pregnancy is high-risk in PAH; planning must be done with the physician
  • Additional evaluation is needed for high-altitude travel and flights

FAQ

Can pulmonary hypertension be treated?

Effective treatments are available in early and correctly classified cases; CTEPH in particular can be completely resolved with surgery.

Can I exercise?

Low-to-moderate intensity exercise programs are beneficial with physician approval. Excessive strain should be avoided.

Are my family members at risk?

In idiopathic or hereditary PAH cases, evaluation of first-degree relatives is recommended.

What is the follow-up interval?

In stable patients, every 3-6 months; more frequent monitoring is needed when treatment changes.